Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FQGY6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,190
Award facts
- Contract value 100% obligated
- $2,189.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,189.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The award was issued on January 21, 2026, with an ultimate completion date of February 11, 2026, under firm fixed-price terms with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded in November 2025 with a $499.999 billion ceiling value and extends through December 31, 2036.
DMS Pharmaceutical Group Inc. serves as a critical regional pharmaceutical supplier within the DLA's broader $30.3 billion PPV-G GEN V acquisition strategy, which establishes multiple prime vendor contractors to support the Department of Defense's recurring medical supply needs worldwide. The company's extensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, positioning it to fulfill diverse pharmaceutical requirements across military healthcare facilities globally. As a SAM-registered small business since 2001, DMS Pharmaceutical Group has demonstrated consistent performance across numerous delivery orders issued by DLA's Medical Supply Chain division, with no identified subcontractor relationships in the award documentation.
Quick answers
Who was awarded contract SPE2DR26FQGY6?
SPE2DR26FQGY6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FQGY6 worth?
The government has obligated $2,190 on SPE2DR26FQGY6.
Is contract SPE2DR26FQGY6 an order under another contract?
Yes. SPE2DR26FQGY6 is a delivery order under SPE2DR25D9156, an indefinite delivery contract.
Was contract SPE2DR26FQGY6 competed?
The extent of competition for SPE2DR26FQGY6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award